15-oxo-Eicosatetraenoic Acid, a Metabolite of Macrophage 15-Hydroxyprostaglandin Dehydrogenase That Inhibits Endothelial Cell Proliferation

0301 basic medicine 0303 health sciences Macrophages Endothelial Cells Arachidonic Acids Monocytes Cell Line 3. Good health Mice 03 medical and health sciences Hydroxyprostaglandin Dehydrogenases Animals Humans Cell Proliferation
DOI: 10.1124/mol.109.057489 Publication Date: 2009-06-18T00:51:03Z
ABSTRACT
The formation of 15-oxo-5,8,11,13-(<i>Z</i>,<i>Z</i>,<i>Z</i>,<i>E</i>)-eicosatetraenoic acid (15-oxo-ETE) as a product from rabbit lung 15-hydroxyprostaglandin dehydrogenase (PGDH)-mediated oxidation 15(<i>S</i>)-hydroperoxy-5,8,11,13-(<i>Z</i>,<i>Z</i>,<i>Z</i>,<i>E</i>)-eicosatetraenoic was first reported more than 30 years ago. However, the pharmacological significance 15-oxo-ETE has never been established. We have now evaluated 15-lipoxygenase (LO)-1-mediated arachidonic (AA) metabolism to in human monocytes and mouse RAW macrophages that stably express 15-LO-1 (R15L cells). A targeted lipidomics approach used identify quantify oxidized lipids were formed. found be major AA-derived LO metabolite when AA given exogenously or released endogenous esterified lipid stores by calcium ionophore (CI) calcimycin (A-23187). This established R15L cells useful vitro model system. Pretreatment with cinnamyl-3,4-dihydroxycyanocinnamate significantly inhibited AA- CI-mediated production [15(<i>S</i>)-HETE] 15-oxo-ETE, confirming role mediating formation. Furthermore, 15(<i>S</i>)-HETE metabolized primarily 15-oxo-ETE. (PGDH) inhibitor 5-[[4-(ethoxycarbonyl)phenyl]azo]-2-hydroxy-benzeneacetic (CAY10397) reduced 15(<i>S</i>)-HETE-mediated dose-dependent manner. confirmed macrophage-derived 15-PGDH responsible for catalyzing conversion Finally, shown inhibit proliferation vascular vein endothelial suppressing DNA synthesis, implicating potential antiangiogenic role. is report describing biosynthesis macrophage/monocytes its ability cell proliferation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (45)
CITATIONS (61)